Cyclic AMP-Adenosine Pathway Induces Nitric Oxide Synthesis in Aortic Smooth Muscle Cells

Hypertension

Volumn 31, Issue 1, 1998, Pages 296-302

  Dubey, Raghvendra K ^a   Gillespie, Delbert G ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2 RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; NITRIC OXIDE; 2',3' DIDEOXYADENOSINE; 9 (2 HYDROXY 3 NONYL)ADENINE; 9-(2-HYDROXY-3-NONYL)ADENINE; ADENINE; ADENOSINE; ADENOSINE 3',5' PHOSPHOROTHIOATE; ADENOSINE RECEPTOR; ADENOSINE-3',5'-CYCLIC PHOSPHOROTHIOATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; NUCLEOTIDE; PHENETHYLAMINE DERIVATIVE;

AORTA MEDIA; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; CYTOSOL; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; THORACIC AORTA;

2-CHLOROADENOSINE; ADENINE; ADENOSINE; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; DIDEOXYADENOSINE; ENZYME INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION; THIONUCLEOTIDES;

EID: 0031606913     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.296     Document Type: Article

References (23)

1. Moncada S, Palmer RM, Higgs EA. NO: Physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 1994;266:E829-E839.
3. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens. 1997;6:88-105.
4. Seo HG, Fujii J, Asahi M, Okado A, Fujiwara N, Taniguchi N. Roles of purine nucleotides and adenosine in enhancing NOSII gene expression in interleukin-1 beta-stimulated rat vascular smooth muscle cells. Free Rad Res. 1997;26:409-418.
5. Imai T, Hirata Y, Kanno K, Marumo F. Induction of nitric oxide synthase by cAMP in rat vascular smooth muscle cells. J Clin Invest. 1994;93:543-549.
6. Schini-Kerth VB, Fisslthaler B, Busse R. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cyclic AMP-dependent mechanism. Am J Physiol. 1994;267:H2483-H2490.
7. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev. 1994;46:449-466.
8. Dubey RK, Mi Z, Gillespie DG, Jackson EK. Cyclic AMP-Adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:765-771.
9. Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension. 1996;27(suppl II):766-773.
10. 2B receptors. Circulation. 1997;96:2656-2666.
11. 1 receptors. J Clin Invest. 1995;96:141-149.
12. Jackson EK, Koehler M, Mi Z, Dubey RK, Tofovic SP, Carcillo JA, Jones GS. Possible role of adenosine deaminase in vaso-occlusive diseases. J Hypertens. 1996;14:19-29.
13. Li J-M, Fenton RA, Cutler BS, Dobson JG Jr. Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol. 1995;269:C519-523.
14. 2 -purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993;109:424-429.
15. Headrick JP, Berne RM. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol. 1990;259:H62-H67.
16. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat mesangial cells. Proc Natl Acad Sci U S A. 1994;91:5387-5391.
17. Ikeda U, Kurosaki K, Ohya K, Shimada K. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cell. Cardiovas Res. 1997;35:168-174.
18. Dubey RK, Gillespie DG, Jackson EK. Adenosine induces nitric oxide synthesis in rat aortic smooth muscle cells. Hypertension. 1996;28:552 (abstract P178).
19. Sciotti VM, Van-Wylen DG. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J Cereb Blood Flow Metab. 1993;13:201-207.
20. 2b receptor. Hypertension. 1996;27(suppl II):786-793.
21. Dubey RK, Mi Z, Gillespie DG, Jackson EK. Cyclic AMP-Adenosine pathway inhibits glomerular mesangial cell growth. Hypertension. 1997;30:506 (abstract P139).
22. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Cardiac fibroblasts metabolize cyclic-AMP to generate adenosine. Hypertension. 1996;28:524 (abstract P7).
23. Dubey RK, Gillespie DG, Jackson EK. Exogenous and cardiac fibroblast cell-derived adenosine inhibits serum-induced collagen and protein synthesis in cardiac fibroblasts. Hypertension. 1996;28:541 (abstract P110).